Want to see LFVN full AI Analyst Report?
Top Page
LifeVantage
(NASDAQ:LFVN)
Select Model
Select Model
Rating:59Neutral
Price Target:
$6.50
▼(-1.66% Downside)
Action:Reiterated
Date:10/06/26
LFVN scores below-average primarily due to weakening revenue and thin, pressured profitability (financial performance) alongside weak price momentum (technicals). The score is partially supported by a conservative balance sheet and positive free cash flow, plus a reasonable P/E and solid dividend yield. Earnings call commentary adds uncertainty due to sharp recent revenue declines and the absence of formal FY2027 guidance, despite encouraging recurring revenue mix and shareholder returns.
Positive Factors
Recurring revenue and retention
Subscription revenue above 75% of Q4 total, alongside improved retention, gives LifeVantage a recurring demand base within its consultant-led model. This can make revenue more predictable, support customer lifetime value, and provide a stronger platform for recovery efforts over the next several quarters.
Negative Factors
Broad-based revenue contraction
Declines across both major geographic regions indicate that weakness is broad rather than isolated to one market. Fewer orders and lower average order size can reduce consultant productivity and customer engagement, making revenue recovery dependent on successfully rebuilding demand and improving the consumer proposition.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring revenue and retention
Subscription revenue above 75% of Q4 total, alongside improved retention, gives LifeVantage a recurring demand base within its consultant-led model. This can make revenue more predictable, support customer lifetime value, and provide a stronger platform for recovery efforts over the next several quarters.
Read all positive factors
LifeVantage Key Performance Indicators (KPIs)
Any
Revenue by Geography
Shows how much sales come from each country or region, revealing dependence on specific markets and the strength of local distributor networks. For LifeVantage, the geographic split highlights where its MLM channel is expanding or contracting, and where regulatory, currency or macro shifts could quickly affect overall revenue.
Shows how much sales come from each country or region, revealing dependence on specific markets and the strength of local distributor networks. For LifeVantage, the geographic split highlights where its MLM channel is expanding or contracting, and where regulatory, currency or macro shifts could quickly affect overall revenue.
Data provided by:
The Fly
The FlyLifeVantage (LFVN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$75.54M
Dividend Yield3.17%
Average Volume (3M)40.74K
Price to Earnings (P/E)15.0
Beta (1Y)0.40
Revenue Growth-20.10%
EPS Growth-49.17%
CountryUS
Employees216
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.40
Shares Outstanding12,589,444
10 Day Avg. Volume28,146
30 Day Avg. Volume40,741
Financial Highlights & Ratios
PEG Ratio-0.31
Price to Book (P/B)2.33
Price to Sales (P/S)0.43
P/FCF Ratio11.73
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue0.40
Enterprise Value/Gross Profit0.52
Enterprise Value/Ebitda8.29
Forecast
1Y Price Target
$6.00Price Target Upside-9.23% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.29
Revenue Forecast (FY)$167.77M
LifeVantage Business Overview & Revenue Model
Company Description
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic exp...
How the Company Makes Money
LifeVantage makes money primarily by selling its health and wellness products through a direct-to-consumer model powered by independent consultants (MLM/direct selling). Revenue is generated from product sales to end customers and to consultants w...
LifeVantage Earnings Call Summary
Earnings Call Date:Aug 27, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Nov 04, 2026
Earnings Call Sentiment Negative
The call presented a mixed picture: the company retains meaningful strengths — a high recurring revenue mix (>75%), attractive gross margins near 78%, a debt-free balance sheet, positive cash from operations, ongoing buybacks and a dividend, and an incoming CEO with a targeted growth agenda — but these positives are outweighed by pronounced headwinds including a 23.1% year-over-year revenue decline, sequential revenue contraction, regional revenue weakness (Americas down 24.8%), reduced net income and adjusted EBITDA margins, higher operating cost pressures (inventory obsolescence, shipping), and a reduced cash balance. Management is focused on brand, consumer relevance, digital investments and operational improvements, but near-term uncertainty remains and the company withheld FY2027 guidance while implementing its strategic plan.Positive Updates
Recurring Revenue Mix and Retention
Subscription-based revenue represented more than 75% of total revenue in Q4 FY2026, and customer retention metrics improved year-over-year, providing a stable recurring revenue foundation.
Negative Updates
Significant Revenue Decline Year-over-Year
Net revenue for Q4 FY2026 was $42.4 million, down 23.1% year-over-year from $55.1 million in Q4 FY2025, driven primarily by fewer orders from the active account base and lower average order size.
Read all updates
Q4-2026 Updates
Positive
Negative
Recurring Revenue Mix and Retention
Subscription-based revenue represented more than 75% of total revenue in Q4 FY2026, and customer retention metrics improved year-over-year, providing a stable recurring revenue foundation.
Read all positive updates
Company Guidance
Management did not provide formal fiscal 2027 guidance amid the recent CEO transition, but gave directional commentary and specific metrics: Q4 revenue was $42.4M (down 23.1% YoY and 3.1% sequentially) with Americas $32.7M (‑24.8%) and Asia‑Pacific/Europe $9.7M (‑16.9%); subscription revenue remained >75% of total and retention improved; gross margin was 78% (vs 79.9% LY), commissions/incentives 41.3% of revenue, SG&A 32.7% (adjusted 32.3%), GAAP operating income $1.7M (adjusted $1.8M), GAAP net income $1.3M or $0.10/share (adjusted $1.4M or $0.11), adjusted EBITDA $2.7M (6.5% of revenue), cash $14.9M with no debt and $10.2M cash from operations (access to $5M revolver); management warned of difficult comparables in FY27 Q1–Q2, expects to pursue brand, digital and operational initiatives to stabilize trends and target a turnaround in FY27 Q3–Q4, plans modest FY27 CapEx of roughly $3.0–$3.5M (vs ~$3.6M in FY26), and will continue balanced capital returns (quarterly dividend $0.05/share; repurchased ~336k shares for ~$2.0M in FY26 with ≈$58.5M remaining under a $60M repurchase authorization).LifeVantage Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
69
Positive
Cash Flow
63
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 182.59M | 228.53M | 200.16M | 213.40M | 206.36M |
| Gross Profit | 141.61M | 183.67M | 158.72M | 170.01M | 168.26M |
| EBITDA | 8.84M | 15.40M | 7.93M | 7.58M | 7.96M |
| Net Income | 5.07M | 9.80M | 2.94M | 2.54M | 3.12M |
Balance Sheet | |||||
| Total Assets | 62.11M | 71.96M | 60.30M | 66.12M | 70.71M |
| Cash, Cash Equivalents and Short-Term Investments | 14.92M | 20.20M | 16.89M | 21.61M | 20.19M |
| Total Debt | 9.87M | 11.68M | 13.61M | 13.09M | 15.76M |
| Total Liabilities | 28.52M | 37.32M | 34.31M | 31.47M | 39.19M |
| Stockholders Equity | 33.59M | 34.64M | 25.99M | 34.65M | 31.52M |
Cash Flow | |||||
| Free Cash Flow | 6.67M | 10.51M | 9.95M | 3.76M | 6.43M |
| Operating Cash Flow | 10.24M | 11.88M | 12.20M | 6.83M | 7.96M |
| Investing Cash Flow | -7.31M | -1.37M | -2.25M | -3.06M | -1.53M |
| Financing Cash Flow | -7.78M | -7.60M | -14.42M | -2.36M | -8.95M |
LifeVantage Technical Analysis
Negative
6.61
Price Trends
6.35
Negative
6.61
Negative
5.84
Positive
Market Momentum
-0.09
Positive
38.67
Neutral
15.76
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LFVN, the sentiment is Negative. The current price of 6.61 is above the 20-day moving average (MA) of 6.18, above the 50-day MA of 6.35, and above the 200-day MA of 5.84, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 38.67 is Neutral, neither overbought nor oversold. The STOCH value of 15.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LFVN.
LifeVantage Risk Analysis
LifeVantage disclosed 51 risk factors in its most recent earnings report. LifeVantage reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
LifeVantage Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | $75.54M | 15.00 | 15.25% | 3.17% | -20.10% | -49.17% | |
57 Neutral | $222.41M | 12.39 | 11.00% | 5.48% | 6.77% | 34.53% | |
55 Neutral | $1.37B | 8.14 | -32.15% | 1.80% | 5.52% | -50.47% | |
47 Neutral | $270.87M | -12.15 | -4.16% | ― | 1.57% | -166.61% | |
45 Neutral | $50.37M | -0.16 | -106.47% | ― | -13.23% | 43.34% |
* Consumer Defensive Sector Average
LFVN
LifeVantage
6.00
-2.79
-31.71%
HLF
Herbalife
13.03
4.47
52.22%
NATR
Nature's Sunshine Products
12.64
-2.06
-14.01%
HAIN
Hain Celestial
0.55
-0.79
-58.73%
USNA
USANA Health
14.66
-5.87
-28.59%
LifeVantage Corporate Events
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
LifeVantage Adopts Calendar-Year Fiscal Reporting Structure
Positive
Oct 5, 2026
On September 29, 2026, LifeVantage Corporation’s board approved changing the company’s fiscal year end from June 30 to December 31 to align its reporting calendar and streamline operational management. The move creates a transition per...
Business Operations and StrategyRegulatory Filings and Compliance
LifeVantage Adopts 2026 New Employee Incentive Plan
Positive
Aug 3, 2026
On July 31, 2026, LifeVantage Corporation’s board approved a 2026 New Employee Long-Term Incentive Plan, closely modeled on its 2017 plan but excluding incentive stock options and limiting awards to recipients permitted under Nasdaq rules. T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.